Ana T. Rocha

Learn More
BACKGROUND Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance. METHODOLOGY/PRINCIPAL FINDINGS This study is a randomized, open-label, controlled clinical trial aimed to evaluate the(More)
  • 1